FDA recall D-0736-2026

Ascend Laboratories, LLC · Class III · drug

Product

Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7255-10.

Reason for recall

Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

Distribution

USA Nationwide

Key facts

Status
Ongoing
Initiation date
2026-06-30
Report date
2026-07-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Bedminster, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0736-2026